Remove condition antiviral
article thumbnail

Managing Viral Infections In Pediatric Patients

Drug Topics

Data was presented at the 44th National Association of Pediatric Nurse Practitioners Conference regarding the effectiveness of vaccines and antivirals in preventing life threatening conditions.

article thumbnail

First treatment conditionally licensed for chronic hepatitis D

European Pharmaceutical Review

Gilead Sciences ’ antiviral medication is recommended as an option for chronic hepatitis D. NICE’s conditional authorisation of Gilead’s chronic hepatitis D treatment The conditional marketing authorisation was granted based on the results of two Phase II studies, MYR202 and MYR203.

87
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

As Omicron cases rise, EMA backs early use of Pfizer’s Paxlovid

pharmaphorum

The EMA’s human medicines committee has said that EU member states can start to offer Pfizer’s oral antiviral Paxlovid as a treatment for people with COVID-19 outside hospital, ahead of a formal approval for the drug.

Hospitals 105
article thumbnail

Japan grants emergency regulatory approval for Shionogi’s Covid-19 drug

Pharmaceutical Technology

Xocova demonstrated clinical symptomatic efficacy for five typical Omicron-linked symptoms, which was the trial’s primary endpoint, as well as antiviral efficacy, the key secondary endpoint, in mild to moderate Covid-19 patients.

98
article thumbnail

Should You Take Paxlovid If You Catch COVID?

The People's Pharmacy

They were compared to over 240,000 similar COVID patients who did not receive antiviral treatment. People treated with the antiviral drug nirmatrelvir were about 25% less likely to suffer long COVID symptoms. The authors conclude that treatment with this antiviral medication significantly reduces the likelihood of long COVID.

article thumbnail

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

pharmaphorum

COVID-19 antiviral medications Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) must be taken within five days of the onset of symptoms, but obtaining these medications within that window is difficult for some. ” COVID-19 antivirals, specifically, have become hard to access for some patients. Accessing antivirals.

article thumbnail

How much is Dovato without insurance?

The Checkup by Singlecare

| How to get Dovato without insurance Dovato treats HIV-1 infection by containing two active antiviral ingredients, dolutegravir and lamivudine. It is only available by prescription, and while the drug has no over-the-counter (OTC) alternatives, other antiviral options exist. Their medical advice is necessary before making any changes.